Trial
NCT04799431
Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Incyte Corporation; National Cancer Institute (NCI)
Condition
Pancreatic Cancer Metastatic
Intervention
Neoantigen Vaccine with Poly-ICLC adjuvant
Why stopped
Study never started
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-09